24 results
424B5
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Prospectus supplement for primary offering
4:52pm
additional indications where fibrosis plays a role.
Many viruses have been shown to recruit cellular (“host”) cyclophilins into the life cycles
424B5
HEPA
Hepion Pharmaceuticals Inc
21 Jul 23
Prospectus supplement for primary offering
4:39pm
where fibrosis plays a role.
Many viruses have been shown to recruit cellular (“host”) cyclophilins into the life cycles of the viruses and therefore
424B5
dv45g 0ml5kn
16 Feb 21
Prospectus supplement for primary offering
5:11pm
424B5
l19 o0ld8
16 Feb 21
Prospectus supplement for primary offering
6:03am
10-KT
vv4xsu mnkzh
26 Mar 18
Annual report (with FYE transition)
12:00am
424B5
9q0m72l7v
7 Oct 15
Prospectus supplement for primary offering
12:00am
10-K
8h1ps gnhsl
29 Sep 14
Annual report
12:00am
10-12G/A
EX-99.1
chce5ms
6 Feb 14
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
0lctk7u06rnqubv
24 Dec 13
Registration of securities (amended)
12:00am